| |
| |
|
| Insider
Information: |
Bradbury Daniel |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
223,469 |
|
|
Indirect Shares
|
3,161,475 |
|
|
| Direct
Value |
$2,468,702 |
|
|
|
Indirect Value
|
$3,772,028 |
|
|
| Total
Shares |
3,384,944 |
|
|
| Total
Value |
$6,240,730 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-06 |
4,655 |
2024-05-06 |
9,981 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
423 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 13 of 17
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-05-05 |
4 |
AS |
$21.12 |
$158,078 |
I/I |
(7,357) |
77,805 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-05-04 |
4 |
AS |
$21.29 |
$382,668 |
I/I |
(17,643) |
79,276 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
• • – |
2010-02-18 |
4 |
OE |
$14.28 |
$636,547 |
I/I |
44,573 |
79,691 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2012-11-21 |
4 |
B |
$1.38 |
$110,504 |
I/I |
80,000 |
80,000 |
2.1 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-04-05 |
4 |
AS |
$22.20 |
$157,620 |
I/I |
(7,100) |
82,805 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-04-04 |
4 |
AS |
$22.19 |
$168,614 |
I/I |
(7,600) |
84,225 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-04-03 |
4 |
AS |
$22.14 |
$227,991 |
I/I |
(10,300) |
85,745 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
• – – |
2012-05-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,548 |
86,197 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-03-03 |
4 |
AS |
$24.53 |
$334,859 |
I/I |
(13,651) |
87,805 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
• – – |
2012-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
88,745 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-03-02 |
4 |
AS |
$23.16 |
$264,411 |
I/I |
(11,349) |
90,535 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-02-02 |
4 |
AS |
$28.55 |
$148,108 |
I/I |
(5,174) |
92,805 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-02-01 |
4 |
AS |
$26.98 |
$538,820 |
I/I |
(19,826) |
93,840 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-03-30 |
4 |
AS |
$44.04 |
$397,680 |
I/I |
(8,852) |
97,562 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
• – – |
2012-07-26 |
4 |
D |
$30.80 |
$746,840 |
D/D |
(24,252) |
97,945 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
• – – |
2012-08-08 |
4 |
D |
$31.00 |
$6,681,306 |
D/D |
(215,526) |
97,945 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-03-29 |
4 |
AS |
$44.81 |
$401,129 |
I/I |
(8,852) |
100,062 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-03-15 |
4 |
AS |
$36.29 |
$323,671 |
I/I |
(8,852) |
102,562 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
• – – |
2012-07-26 |
4 |
OE |
$11.95 |
$430,200 |
D/D |
36,000 |
103,615 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-03-14 |
4 |
AS |
$37.10 |
$338,221 |
I/I |
(8,852) |
105,062 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-02-23 |
4 |
AS |
$38.97 |
$347,350 |
I/I |
(8,852) |
107,562 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-02-22 |
4 |
AS |
$38.65 |
$345,368 |
I/I |
(8,852) |
110,062 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-02-10 |
4 |
AS |
$44.42 |
$402,451 |
I/I |
(8,852) |
112,562 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-02-09 |
4 |
AS |
$46.33 |
$411,856 |
I/I |
(8,852) |
115,062 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-01-24 |
4 |
AS |
$35.37 |
$518,281 |
I/I |
(14,631) |
117,562 |
0 |
- |
|
423 Records found
|
|
Page 13 of 17 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
